title: HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy.
authors.affiliation: Department of Anesthesiology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St., Boston, MA 02115, USA.
authors.forename: Frank
authors.initials: F
authors.lastname: Alexis
authors.forename: Pamela
authors.initials: P
authors.lastname: Basto
authors.forename: Etgar
authors.initials: E
authors.lastname: Levy-Nissenbaum
authors.forename: Aleksandar F
authors.initials: AF
authors.lastname: Radovic-Moreno
authors.forename: Liangfang
authors.initials: L
authors.lastname: Zhang
authors.forename: Eric
authors.initials: E
authors.lastname: Pridgen
authors.forename: Andrew Z
authors.initials: AZ
authors.lastname: Wang
authors.forename: Shawn L
authors.initials: SL
authors.lastname: Marein
authors.forename: Katrina
authors.initials: K
authors.lastname: Westerhof
authors.forename: Linda K
authors.initials: LK
authors.lastname: Molnar
authors.forename: Omid C
authors.initials: OC
authors.lastname: Farokhzad
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D016503:Drug Delivery Systems; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism; D006801:Humans; D008301:Maleimides / Q000138:chemical synthesis / Q000737:chemistry; D053758:Nanoparticles / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000138:chemical synthesis / Q000737:chemistry; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D008301:Maleimides; D011092:Polyethylene Glycols; D018719:Erb-b2 Receptor Tyrosine Kinases; C043592:maleimide